Literature DB >> 7596894

Antenatal antecedents of moderate and severe cerebral palsy.

L Palmer1, E Blair, B Petterson, P Burton.   

Abstract

Aetiological relationships between cerebral palsy, preterm birth, small-for-gestational-age (SGA) birth and selected feto-maternal factors were investigated in a case-control study of all moderate and severe cerebral palsy cases born in Western Australia between 1980 and 1986 (n = 215). Cases were individually matched to three controls of the same gender and plurality born in the same year. Two of the controls were matched to the index cases for gestational age, one of which was also matched for birthweight. Pre-eclampsia and urinary tract infections were not significantly associated with cerebral palsy. The significant association of antepartum haemorrhage with cerebral palsy was accounted for by its associations with preterm birth. Congenital malformations and non-cerebral palsy neurological disorder were significantly associated with cerebral palsy; these associations were only partially accounted for by adjusting for preterm birth and small-for-gestational-age birth. This study shows that some of the risk of cerebral palsy associated with the antenatal antecedents of some common feto-maternal factors is mediated through preterm birth, confirming the importance of interrelationships between antenatal antecedents in the aetiology of some cerebral palsy. Perinatal and post-neonatal causes now account for only around 20% of all cerebral palsy. Future reductions in cerebral palsy incidence may therefore depend on acquiring greater knowledge of inter-relationships between antenatal antecedents.

Entities:  

Mesh:

Year:  1995        PMID: 7596894     DOI: 10.1111/j.1365-3016.1995.tb00132.x

Source DB:  PubMed          Journal:  Paediatr Perinat Epidemiol        ISSN: 0269-5022            Impact factor:   3.980


  9 in total

Review 1.  Continuous cardiotocography (CTG) as a form of electronic fetal monitoring (EFM) for fetal assessment during labour.

Authors:  Zarko Alfirevic; Declan Devane; Gillian Ml Gyte; Anna Cuthbert
Journal:  Cochrane Database Syst Rev       Date:  2017-02-03

Review 2.  Preeclampsia and Neurodevelopmental Outcomes: Potential Pathogenic Roles for Inflammation and Oxidative Stress?

Authors:  Aaron Barron; Cathal M McCarthy; Gerard W O'Keeffe
Journal:  Mol Neurobiol       Date:  2021-01-25       Impact factor: 5.590

3. 

Authors:  H Schneider
Journal:  Arch Gynecol Obstet       Date:  1995-12       Impact factor: 2.344

4.  Maternal hypertension and neurodevelopmental outcome in very preterm infants.

Authors:  P H Gray; M J O'Callaghan; H A Mohay; Y R Burns; J F King
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1998-09       Impact factor: 5.747

5.  The Development of Extremely Preterm Infants Born to Women Who Had Genitourinary Infections During Pregnancy.

Authors:  Alan Leviton; Elizabeth N Allred; Karl C K Kuban; T Michael O'Shea; Nigel Paneth; Andrew B Onderdonk; Raina N Fichorova; Olaf Dammann
Journal:  Am J Epidemiol       Date:  2015-12-13       Impact factor: 4.897

6.  Prevalence and pathogenesis of congenital anomalies in cerebral palsy.

Authors:  Peter O D Pharoah
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2007-04-11       Impact factor: 5.747

7.  Mediators of the association between pre-eclampsia and cerebral palsy: population based cohort study.

Authors:  Kristin Melheim Strand; Runa Heimstad; Ann-Charlotte Iversen; Rigmor Austgulen; Stian Lydersen; Guro L Andersen; Lorentz M Irgens; Torstein Vik
Journal:  BMJ       Date:  2013-07-09

8.  Optimal fetal growth for the Caucasian singleton and assessment of appropriateness of fetal growth: an analysis of a total population perinatal database.

Authors:  Eve M Blair; Yingxin Liu; Nicholas H de Klerk; David M Lawrence
Journal:  BMC Pediatr       Date:  2005-05-24       Impact factor: 2.125

9.  Congenital anomalies in multiple births after early loss of a conceptus.

Authors:  P O D Pharoah; S V Glinianaia; J Rankin
Journal:  Hum Reprod       Date:  2008-12-05       Impact factor: 6.918

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.